The presence of pulmonary hypertension (PH) didn’t increase mortality after a heart transplant, according to a new study. The…
Articles by Steve Bryson, PhD
AI Therapeutics has begun dosing in a clinical trial testing inhaled LAM-001, a potential disease-modifying therapy for pulmonary…
Older age and high blood pressure in the pulmonary arteries raise the risk of complications with balloon pulmonary angioplasty (BPA),…
Exposure to air pollutants significantly increased the risk of pulmonary hypertension (PH), according to a U.K. population study that…
Persistent exercise intolerance in pulmonary arterial hypertension (PAH) patients with treatment-related improvements in blood pressure was associated with impaired…
Molecular differences are evident between infants with severe bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH) and those with severe…
Infants with persistent pulmonary hypertension of the newborn (PPHN) who have blood type O responded better to inhaled nitric…
Oral Uptravi (selexipag) provided similar clinical benefits for adults with connective tissue disease (CTD) associated with pulmonary arterial…
Self-compassion, the act of being kind to oneself, was a significant predictor of anxiety and depression in adults with…
Researchers have identified a significant risk factor that affects the prognosis of people with chronic thromboembolic pulmonary hypertension (CTEPH) in…
Adding sotatercept to standard therapies significantly improved the six-minute walking distance by more than 40 meters (131 feet) compared with…
An investigational once-daily therapy, a single tablet combining macitentan and tadalafil, significantly improved pulmonary blood flow compared with macitentan or…